ArticleFrontiers in neurology2021

Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy.

Zara A Ioannides et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.